1. Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;131:30-39.PMID:
16831587.
2. Orlowska J. Serrated lesions and hyperplastic (serrated) polyposis relationship with colorectal cancer: classification and surveillance recommendations. Gastrointest Endosc 2013;77:858-871.PMID:
23684091.
3. Jasperson KW, Kanth P, Kirchhoff AC, et al. Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum 2013;56:1211-1216.PMID:
24104994.
4. Snover DC, Ahnen DJ, Burt RW, Odze RD. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Theise ND. eds. WHO classification of tumours of the digestive system. Lyon: IARC Press, 2010:160-165.
5. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 2001;25:177-184.PMID:
11176066.
6. Boparai KS, Mathus-Vliegen EM, Koornstra JJ, et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094-1100.PMID:
19710031.
7. Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010;59:1222-1225.PMID:
20584785.
8. Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut 2013;62:404-408.PMID:
22490521.
9. Rubio CA, Stemme S, Jaramillo E, Lindblom A. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006;38:266-270.PMID:
16528654.
10. Lage P, Cravo M, Sousa R, et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 2004;99:1779-1784.PMID:
15330918.
11. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143:844-857.PMID:
22763141.
12. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 2008;37:25-46.PMID:
18313538.
13. Hazewinkel Y, Tytgat KM, van Eeden S, et al. Incidence of colonic neoplasia in patients with serrated polyposis syndrome who undergo annual endoscopic surveillance. Gastroenterology 2014;147:88-95.PMID:
24657624.
14. Miwata T, Hiyama T, Oka S, et al. Clinicopathologic features of hyperplastic/serrated polyposis syndrome in Japan. J Gastroenterol Hepatol 2013;28:1693-1698.PMID:
23800207.
15. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-350.PMID:
16454841.
16. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003;349:2191-2200.PMID:
14657426.
17. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003;27:65-81.PMID:
12502929.
18. Biswas S, Ellis AJ, Guy R, Savage H, Madronal K, East JE. High prevalence of hyperplastic polyposis syndrome (serrated polyposis) in the NHS bowel cancer screening programme. Gut 2013;62:475.
19. Elorza G, Enríquez-Navascués JM, Bujanda L, Larzábal M, Gil Lasa I, Martí L. Phenotype characteristics of patients with colonic serrated polyposis syndrome: a study of 23 cases. Cir Esp 2014;92:659-664.PMID:
24795265.
20. Moreira L, Pellisé M, Carballal S, et al. High prevalence of serrated polyposis syndrome in FIT-based colorectal cancer screening programmes. Gut 2013;62:476-477.PMID:
22982987.
21. Ferrández A, Samowitz W, DiSario JA, Burt RW. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 2004;99:2012-2018.PMID:
15447765.
22. Vemulapalli KC, Rex DK. Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps. Gastrointest Endosc 2012;75:1206-1210.PMID:
22425271.
23. Guarinos C, Sánchez-Fortún C, Rodríguez-Soler M, et al. Clinical subtypes and molecular characteristics of serrated polyposis syndrome. Clin Gastroenterol Hepatol 2013;11:705-711.PMID:
23376323.
24. Rosty C, Walsh MD, Walters RJ, et al. Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol 2013;37:434-442.PMID:
23211288.
25. Kalady MF, Jarrar A, Leach B, et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 2011;54:164-170.PMID:
21228663.
26. Knabe M, Behrens A, Ell C, Tannapfel A, Pohl J. Endoscopic management for patients with serrated polyposis syndrome is feasible and effective: a prospective observational study at a tertiary centre. Z Gastroenterol 2014;52:802-806.PMID:
25111719.
27. Hui VW, Steinhagen E, Levy RA, et al. Utilization of colonoscopy and pathology reports for identifying patients meeting the World Health Organization criteria for serrated polyposis syndrome. Dis Colon Rectum 2014;57:846-850.PMID:
24901685.
28. Toyoshima N, Sakamoto T, Makazu M, et al. Prevalence of serrated polyposis syndrome and its association with synchronous advanced adenoma and lifestyle. Mol Clin Oncol 2015;3:69-72.PMID:
25469272.
30. Kim KM, Lee EJ, Ha S, et al. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am J Surg Pathol 2011;35:1274-1286.PMID:
21836485.
31. Chung SJ, Kim YS, Yang SY, et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy. J Gastroenterol Hepatol 2010;25:519-525.PMID:
20370730.
32. Song KB, Atkinson C, Frankenfeld CL, et al. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 2006;136:1347-1351.PMID:
16614428.
34. Orlowska J. Hyperplastic polyposis syndrome and the risk of colorectal cancer. Gut 2012;61:470-471.
35. Orlowska J, Kiedrowski M, Kaminski FM, Regula J, Butruk E. Hyperplastic polyposis syndrome in asymptomatic patients: the results from the colorectal-cancer screening program. Virchows Arch 2009;455:47.
36. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.PMID:
21296855.
37. Conteduca V, Sansonno D, Russi S, Dammacco F. Precancerous colorectal lesions (review). Int J Oncol 2013;43:973-984.PMID:
23900573.
38. Brenner H, Altenhofen L, Kretschmann J, et al. Trends in adenoma detection rates during the first 10 years of the German screening colonoscopy program. Gastroenterology 2015;149:356-366.e1.PMID:
25911510.
39. Kim HB, Lee YJ, Shim JY, Lee HR. The association between coronary calcification and adenomatous polyps of colon in Korean adults. Clin Res Hepatol Gastroenterol 2014;38:649-654.PMID:
24969685.
40. Rex DK. Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol 2006;101:2866-2877.PMID:
17227527.